Organization
Peking University
38 clinical trials
Clinical trial
A Multi-Center, Multi-Cohort Study of the Efficacy and Safety of Anlotinib, TQB2450, and Albumin-bound Paclitaxel in CLDN18.2-regimen-failed Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus: Not yet recruiting, Estimated PCD: 2025-08-25
Clinical trial
Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on AnhedoniaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Prospective Multicentre Trial of Biliary Drainage Plus Hepatic Arterial Infusion Chemotherapy Versus Biliary Drainage Plus Best Supportive Care in Locally Advanced Perihilar Cholangiocarcinomas.Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
The Characteristics of Treatment Resistant Schizophrenia From the Illness OnsetStatus: Not yet recruiting, Estimated PCD: 2024-10-12
Clinical trial
Investigator-initiated Trial of Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti-PD-1 in Patients With PD-1 Resistant Digestive System CancersStatus: Active (not recruiting), Estimated PCD: 2023-02-01
Clinical trial
Single Cell Analysis of CXCL13+PD1+ CD8 T Cell in Association With Resistance to Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLCStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Real-world Study to Explore and Evaluate Individualized Targeted Agents for Patients of Digestive Cancers Based on Molecular Characteristics After Standard Therapy Failure in ChinaStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
FTiH, Phase 1 Investigator-Initiated Trial (IIT) to Evaluate the Safety, Feasibility, Cellular Kinetics, and Preliminary Antitumor Activity of AZD6422 in Adult Participants With Advanced or Metastatic CLDN18.2+ GI TumorsStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Single-arm, Open-label, Dose Exploratory Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Autologous Humanized MAGE-A4-directed T Cell Receptor Engineered T Cell (JWTCR001) in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage Hepatocellular Carcinoma Out Up-to-seven: a Multi-center Randomized Controlled Trial.Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Single-center, Open-label, Single-arm Clinical Study of the Safety and Efficacy of KD-496 CAR-T Therapy in Advanced NKG2DL+/CLDN18.2+ Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2026-06-30
Clinical trial
An Early Exploratory Clinical Trial of Claudin18.2-Targeted Chimeric Antigen Receptor T Cell Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma.Status: Recruiting, Estimated PCD: 2025-11-16
Clinical trial
Targeted Treatment Based on ctDNA Genotyping Combined With Tislelizumab and HAIC as Salvage Treatment for Advanced Colorectal Cancer Liver Metastasis Failed From Standard Systemic Treatment (SALVLIV Trial)Status: Recruiting, Estimated PCD: 2026-01-23
Clinical trial
A Phase 1, Open-Label Study Evaluating the Safety, Tolerability and Efficacy of (LCAR)-G08, a Chimeric Antigen Receptor (CAR)-T Cell Therapy Targeting Guanylyl Cyclase C (GCC) in Subjects With Advanced Gastrointestinal TumorsStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Single Arm, Open Label, Multicenter Clinical Trial of Linperlisib Combined With CHOP Regimen Followed by Autologous Hematopoietic Stem Cell Transplantation and Linperlisib Monotherapy Maintenance for Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) PatientsStatus: Recruiting, Estimated PCD: 2027-01-31
Clinical trial
A Phase I, Open-label, Dose Escalation Clinical Trial to Assess the Safety, Efficacy, Tolerability and Pharmacokinetics of the Recombinant Humanized Anti-PD1 Monoclonal Antiody (JS001) in Combination With Recombinant Humanized Anti-HER2 Monoclonal Antibody-MMAE Conjugate (RC48-ADC) in Treatment of HER2-Positive Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase I Clinical Study of YK0901 Injection for the Treatment of Advanced Solid Tumors With HLA-A * 11:01 Positive and KRAS G12V MutationStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
An Open Label, Dose-escalation and Extension, Phase I Clinical Study on Evaluating Safety, Tolerability and Pharmacodynamics of Intravenous Administration of IDOV-SAFE in Patients With Advanced Malignant Solid Tumors Who Have Failed in Standard Treatment.Status: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
An Open-Label, Single-Arm, Dose-Exploration Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of CT048 in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2023-06-30
Clinical trial
A Multicenter, Single-arm, Exploratory Clinical Study of Utidelone Combined With Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer That Has Failed Standard First-line TherapyStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
An Open Label, Single/Multiple Dose Exploratory Clinical Study to Evaluate the Safety, Efficacy, and Cytokinetics of Autologous Humanized Anti-claudin18.2 Chimeric Antigen Receptor T Cell in Advanced Solid Tumor SubjectsStatus: Completed, Estimated PCD: 2021-03-20
Clinical trial
Hepatic Arterial Infusion Chemotherapy Combine With Lenvatinib and PD-1 Inhibitors for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis.Status: Recruiting, Estimated PCD: 2023-12-29
Clinical trial
A Multicenter, Open-label, Randomized, Controlled Phase II Study to Evaluate the Efficacy and Safety of Afatinib Versus Irinotecan as a Second-line and Above Treatment for Advanced ALTRK-negative ESCCStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Prospective, Non-randomized, Multicenter, Phase II Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Unresectable Recurrent or Metastatic Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Hepatic Arterial Infusion Chemotherapy With Oxaliplatin, 5-fluorouracil and Bevacizumab Plus Intravenous Toripalimab for Advanced Biliary Tract CancerStatus: Completed, Estimated PCD: 2023-05-19
Clinical trial
Efficacy and Safety of Plerixafor in Patients With Poorly Mobilized LymphomaStatus: Recruiting, Estimated PCD: 2023-12-20
Clinical trial
Exploratory Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Clinical trial
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Inoperable Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine TumorsStatus: Not yet recruiting, Estimated PCD: 2025-06-05
Clinical trial
Dose Higher Doses of Botulinum Toxin Show Better Intensity and Duration in the Treatment of Gummy SmileStatus: Completed, Estimated PCD: 2020-08-20
Clinical trial
Intranasal Dexmedetomidine Versus Midazolam for Premedication in Deep-sedated Pediatric Dental Patients: a Double-blinded, Prospective, Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-05-01
Clinical trial
A Phase Ib Study to Evaluate Efficacy, Safety and Tolerability of KN026 Combined With KN046 in Subjects With HER2 Positive Solid TumorStatus: Completed, Estimated PCD: 2022-09-22
Clinical trial
Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Clinical trial
Toripalimab With Paclitaxel and Cisplatin as Neoadjuvant Treatment for Esophageal Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Phase I Clinical Study of UTAA06 Injection in Treatment of Patients With Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma Patients Failed in First-line Chemotherapy: A Phase II StudyStatus: Terminated, Estimated PCD: 2021-04-25
Clinical trial
A Multicenter II Study to Compare KN026 and KN046 Versus Oxaliplatin, Capecitabine Combined KN026 and KN046 in Patients With HER2-positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.Status: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Prospective, Multi-cohort, National Multicenter Real-world Study to Evaluate the Efficacy and Safety of Liposome IrinotecanStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Investigating the Effects of Lithium Carbonate on Suicide and Self-harm in Adolescents and Young Adults With Bipolar Disorder in ChinaStatus: Recruiting, Estimated PCD: 2024-12-31